wow, i just can't believed it how this site really change my life'....you guys have checked it out! thank you so much for the recommendation OP
PLX now back to a $3 Buck Chuck and Obama back to new all time low approval of 37%. Just the facts folks.
Oral GCD is gonna be a game changer for that whole market place. PLX's end game is oral not injection. We will get all the business as soon as we can offer an alternate non-intravenous drug. That Phase IIa is gonna fly by and I imagine it will get a conditional, fast track licensing from the FDA for the fact that Eleyseo is already marketed.
This stock is a buy at these prices, we just have to wait on whoever is manipulating the market to decide it can go up.
Sleeper hit. A breakout is going to happen sometime this year.
Protalix BioTherapeutics Announces New Data on ELELYSO(TM) (taliglucerase alfa) and Oral GCD to be Presented at the European Working Group on Gaucher Disease 2014 11th Meeting
Dr. Stone you made the call on PLX correct keep up the great postings.
PLX back to $3 Buck Chuck and Obama approval back to new all time low of 37% both losers.
PLX share price today headed lower like Obama approval rating now only 37%. Timber sell the dog now before it is a $3 Buck Chuck again.
I feel like this stock finally moved out of the doldrums of the $3.80 range. All it took was market expansion into Australia, Canada, the retiring of the CEO and the start of a Phase 2a study. This stock is setting itself up for a run. It usually trades on low volume and you'll see it open .20-.30 cents up from the action on the Israeli exchange.
I imagine the short term is still going to be a little choppy, but the market expansion should increase sales. And assuming that Brazil is following the terms of the contract they signed, then the next 7 quarters should see increased sales in that market above analyst expectations. It's not hard to add patients, once they have a prescription they keep it for the rest of their life.
Amen to that ice_yachtzeee_me .
Also, I think NYSE market makers hold inventory of stock. NYSE market makers can manipulate stocks to their advantage if they choose when there is little volume. NASDAQ market makers do not hold inventory. Over a hundred biotechs trade on combined NASDAQGS and NASDAQCM, including all the top, profitable ones. All shareholders tell Protalix to move stock to NASDAQ.
I hope his resignation isn't related to Brazil not paying funds per the contract...wouldn't bode well for earnings.
Correction, Remicade biosimilars have been approved in Europe in 2013, not Enbrel biosimilars. Enbrel patent in Europe expires in 2015. I would like to see Protalix do an injection Enbrel biosimilar outsourced to a partner, while Protalix starts development of oral Anti-TNF.
Anyway, potential blockbuster in oral Anti-TNF. You might see the company that owns Enbrel come knocking on Protalix's door. Or maybe Amgen or Pfizer might want it, since both companies currently license and market Enbrel.
For shareholders, PLX stock has done little over the 12 years he has been CEO. Pipeline was poorly scheduled with many years between potential commercial drugs. Gaucher drug was approved in 2012. Two years later most other drugs are in phase 1. Fabry drug is still two to three years away from reaching commercial stage. I do not know timing on oral version of Elelyso. Maybe it can get accelerated approval since it is the same active protein as injection Elelyso.
He could have found more partners. He has potential Enbrel injection biosimilar, but did not partner with any company to develop one for Europe, where the patent expired years ago. No news on TEVA partnership after they discontinued the two drugs they were developing together back in 2009. No partnerships resulted in the poorly scheduled pipeline with Protalix developing drugs by itself at a slow pace.
So I would agree that it is good news for stock that Dr. Aviezer is retiring as CEO. Hopefully, Protalix finds a new CEO which can speed development up.
I haven't been on this msg board for abt 2 years...but for some unexplainable reason still hold a few shares...I could not have given a better assesment than nuselrami's post !!! Its abt time !!! I might actually get interested in whom they bring in... All the best